Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg

@article{Leufkens2006CognitivePA,
  title={Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg},
  author={Tim R. M. Leufkens and Annemiek Vermeeren and Beitske E. Smink and Peter van Ruitenbeek and Johannes Gerardus Ramaekers},
  journal={Psychopharmacology},
  year={2006},
  volume={191},
  pages={951-959}
}
Alprazolam extended-release (XR) is approved for the treatment of panic disorder. This sustained formulation is absorbed in a delayed manner and is therefore expected to produce fewer and less severe side effects than its immediate release equivalent (alprazolam IR). The effect of alprazolam XR on potentially dangerous daily activities, such as driving a car, is expected to be less as compared to alprazolam IR. The present study was designed to compare the effects of alprazolam XR (1 mg) and… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 47 references

The relationship between drivers’ blood alcohol concentration (BAC) and actual driving performance during high speed travel

  • JW Louwerens, ABM Gloerich, G de Vries, KA Brookhuis, JF O’Hanlon
  • Alcohol Drugs Traffic Saf
  • 1987
Highly Influential
3 Excerpts

Acute effects of 3 , 4 - methylenedioxymethamphetamine ( MDMA ) on behavioral measures of impulsivity : alone and in combination with alcohol

  • JG Ramaekers, Kuypers KPC
  • Neuropsychopharmacology
  • 2006

Is it safe to drive a car when treated with anxiolytics? Evidence from on-the-road driving studies during normal traffic

  • JC Verster, DS Veldhuijzen, ER Volkerts
  • Curr Psychiatry Rev 1:215–225
  • 2005
2 Excerpts

Similar Papers

Loading similar papers…